Chaoju Eye Care (02219) has announced a share repurchase transaction executed on September 10, spending approximately HK$21,400 to acquire 8,500 of its own shares.
The buyback was disclosed in an official filing, highlighting the company's ongoing capital management strategy. This move reflects the firm's commitment to enhancing shareholder value through strategic market operations.
Further details regarding the repurchase price per share were not specified in the announcement. The transaction aligns with the company's broader financial policies and market conditions at the time of purchase.